Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Return on Equity (2016 - 2025)

Gyre Therapeutics (GYRE) has disclosed Return on Equity for 15 consecutive years, with 0.12% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 19.0% to 0.12% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.12% through Dec 2025, up 19.0% year-over-year, with the annual reading at 0.15% for FY2025, 28.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.12% at Gyre Therapeutics, up from 0.1% in the prior quarter.
  • The five-year high for Return on Equity was 0.3% in Q1 2023, with the low at 1.85% in Q1 2022.
  • Average Return on Equity over 5 years is 0.58%, with a median of 0.25% recorded in 2023.
  • The sharpest move saw Return on Equity soared 215bps in 2023, then plummeted -185bps in 2024.
  • Over 5 years, Return on Equity stood at 1.46% in 2021, then skyrocketed by 105bps to 0.07% in 2022, then tumbled by -2655bps to 1.72% in 2023, then surged by 96bps to 0.06% in 2024, then soared by 295bps to 0.12% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.12%, 0.1%, and 0.12% for Q4 2025, Q3 2025, and Q2 2025 respectively.